Y. C. G.

Pleural Disease: A forgotten frontier in respiratory research (2006)

Y.C.G.

Respirology Year-In-Review 2005: Clinical Science (2006)

Y.C.G.

Malignant mesothelioma (2006)

Y.C.G

Pleural Effusion: Overview (2006)

Y.C.G.

Pleural Effusion: Transudate vs Exudate (2006)

Y.C.G.

The Pleural Cavity (2006)

Y.C.G.

Current Management of Malignant Pleural Mesothelioma (2006)

Y.C.G.

Lymphocytes in pleural effusions (2005)

Y.C.G.

Sv40 as a causative agent in mesothelioma- a new twist to the story (2005)

Y.C.G.

Transforming Growth Factor-beta: A potential new agent for pleurodesis (2005)

Y.C.G., ...

Empyema, Necrotizing Pneumonia and Lung Abscess (2005)

Y.C.G., R.J.O.

Pneumothorax, Chylothorax, Hemothorax and Fibrothorax (2005)

Y.C.G.

CD56 bright natural killer cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation (2004)

R.J.O, ...

Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size (2004)

Y.C.G., ...

Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size (2004)

Y.C.G., ...

Adenosine deaminase for lymphocytic pleural effusions (2004)

Y.C.G.

Management of pleural effusions in acute medical settings: A practical guide (2004)

Y.C.G., R.J.O.

Ongoing search for effective intrapleural therapy for empyema: Is streptokinase the answer? (2004)

Y.C.G.

Variations in pleural fluid WBC count and differential counts with different sample containers and different methods (2003)

Y.C.G., ...

Transforming Growth Factor-beta induces collagen synthesis without inducing IL-8 production in pleural mesothelial cells (2003)

Y.C.G., ...

Ultrasound-guided thoracentesis: Is it a safer method? (2003)

...

Benign asbestos pleural diseases (2003)

...

Cytokines in Pleural Diseases (2003)

Y.C.G.

Experimental Models for Pleural Disease (2003)

Y.C.G.

Future Directions (2003)

Y.C.G.

Immunologia das Citocinas: Perspectiveas Futuras (Cytokine Immunology in Pleural Effusion Management - Future Directions) (2003)

Y.C.G.

Authors' Reply: Earlier study on asbestos workers, ILO scores and oxygenation (Letter) (2003)

Y.C.G., ...

Pleural space as a site of ectopic gene delivery: Transfection of pleural mesothelial cells with systemic distribution of gene product (2003)

Y.C.G., ...

Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis (2003)

Y.C.G., ...

A comparison of the thin-section CT features in asbestosis and idiopathic pulmonary fibrosis (2003)

...

Textbook of Pleural Diseases (2003)

Y.C.G

Pleural fluid levels of interleukin-5 and eosinophils are closely related (2002)

Y.C.G., ...

Prevalence and clinical course of pleural effusions after coronary artery bypass and cardiac surgery (2002)

...

Vascular Endothelial Growth Factor: the key mediator in pleural effusion formation (2002)

Y.C.G.

Clinical and Palliative Care Aspects of Malignant Mesothelioma (2002)

Y.C.G., ...

Comparing Transforming Growth Factor (TGF) -beta2, talc and bleomycin as pleurodesing agents in sheep (2002)

Y.C.G., ...

Adenosine deaminase levels in non-tuberculous lymphocytic pleural effusions (2001)

Y.C.G., ...

Coulter counter registers talc particles as leukocytes (letter) (2001)

Y.C.G.

Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment - Clinical and histologic features (2001)

Y.C.G., M.A.C., ...

How does pleurodesis affect lung function? (2001)

Y.C.G.

Pleurodesis for recurrent pleural effusions in the new millenium (2001)

Y.C.G., ...

The many faces of Transforming Growth Factor-beta in pleural diseases (2001)

Y.C.G.

Comparing Transforming Growth Factor beta-2 and fibronectin as pleurodesing agents (2001)

Y.C.G., ...

Increased body mass index is related to apparent circumscribed pleural thickening on plain chest radiographs (2001)

Y.C.G., ...

Transforming Growth Factor Beta2 induced pleurodesis is not inhibited by corticosteroids (2001)

Y.C.G., ...